Search Results - "Alorfi, Nasser M"

Refine Results
  1. 1

    Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials by Alorfi, Nasser M.

    Published in Frontiers in pharmacology (23-09-2022)
    “…Background: Fibromyalgia is a chronic neurological condition characterized by widespread pain. The effectiveness of current pharmacological treatments is…”
    Get full text
    Journal Article
  2. 2

    Protective role of resveratrol against VCM-induced hepatotoxicity in male wistar rats by Alshehri, Fahad S, Alorfi, Nasser M

    Published in Frontiers in pharmacology (07-02-2023)
    “…Vancomycin is a glycopeptide antibiotic with a high risk of acute liver injury. Resveratrol is believed to protect the liver against toxicity. To investigate…”
    Get full text
    Journal Article
  3. 3

    Understanding migraine in Saudi society: An assessment of public knowledge and attitudes: A cross-sectional study by Alshehri, Fahad S, Ashour, Ahmed M, Alharbi, Adnan S, Hakami, Alqassem Y, Alorfi, Nasser M

    Published in PloS one (21-06-2024)
    “…This study aims to assess the knowledge and perceptions of the public toward migraine in Saudi Arabia. This cross-sectional survey assessed the knowledge and…”
    Get full text
    Journal Article
  4. 4

    Assessment of community pharmacists' knowledge about drug-drug interactions in Jeddah, Saudi Arabia by Alorfi, Nasser M, Alqurashi, Roaya S, Algarni, Alanood S

    Published in Frontiers in pharmacology (01-06-2023)
    “…Drug-drug interactions (DDIs) have the potential to result in severe adverse drug events and profoundly affect patient outcomes. The pivotal role community…”
    Get full text
    Journal Article
  5. 5

    Evaluation of Pharmacology and Pathophysiology Knowledge of Epilepsy among Senior Pharmacy Students: A Single Center Experience by Alorfi, Nasser M, Ashour, Ahmed M, Bafhaid, Hanouf S, Alshehri, Fahad S

    Published in Medicina (Kaunas, Lithuania) (28-04-2023)
    “…Epilepsy is a chronic disease that causes substantial morbidity and mortality. Pharmacists represent an integral role in managing patients with epilepsy. The…”
    Get full text
    Journal Article
  6. 6

    Amphetamines in child medicine: a review of ClinicalTrials.gov by Alalalmeh, Samer O., Hegazi, Omar E., Shahwan, Moyad, Alshehri, Fahad S., Ashour, Ahmed M., Algarni, Alanood S., Alorfi, Nasser M.

    Published in Frontiers in pharmacology (03-10-2023)
    “…Background: Globally, the use of amphetamines as therapeutic agents in pediatric medicine is a crucial area of concern, especially given the population’s…”
    Get full text
    Journal Article
  7. 7

    Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database by Alorfi, Nasser M, Alshehri, Fahad S, Haseeb, Abdul

    Published in Frontiers in public health (09-03-2023)
    “…Monkeypox (mpox), a zoonotic viral infection, poses a global threat that is being acknowledged at the national and international levels. This systematic review…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Pharmacological Methods of Pain Management: Narrative Review of Medication Used by Alorfi, Nasser M

    Published in International journal of general medicine (31-08-2023)
    “…Pain management is a critical aspect of healthcare, aimed at alleviating discomfort and improving the quality of life for individuals experiencing acute or…”
    Get full text
    Journal Article
  13. 13

    Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches by Alorfi, Nasser M, Ashour, Ahmed M, Alharbi, Adnan S, Alshehri, Fahad S

    Published in Medicine (Baltimore) (24-05-2024)
    “…Glioblastoma (GBM) is a highly aggressive primary malignant brain tumor with a dismal prognosis despite current treatment strategies. Inflammation plays an…”
    Get full text
    Journal Article
  14. 14

    Use and effectiveness of PCSK-9 inhibitors in heart diseases: A review by Alorfi, Nasser M, Harbi, Maan H, El Hajj, Maguy Saffouh, Alayoubi, Samha, Ibrahim, Nihal Abdalla, Alayoubi, Fakhr Z

    Published in Medicine (Baltimore) (06-09-2024)
    “…Proprotein Convertase Subtilisin/Kexin type-9 (PCSK-9) inhibitors have recently used in the management of different cardiac complications. Several clinical…”
    Get full text
    Journal Article
  15. 15

    Disrupted endothelial cell heterogeneity and network organization impair vascular function in prediabetic obesity by Wilson, Calum, Zhang, Xun, Lee, Matthew D., MacDonald, Margaret, Heathcote, Helen R., Alorfi, Nasser M.N., Buckley, Charlotte, Dolan, Sharron, McCarron, John G.

    Published in Metabolism, clinical and experimental (01-10-2020)
    “…Obesity is a major risk factor for diabetes and cardiovascular diseases such as hypertension, heart failure, and stroke. Impaired endothelial function occurs…”
    Get full text
    Journal Article
  16. 16

    Public Awareness of Alzheimer’s Disease: A Cross-Sectional Study from Saudi Arabia by Alorfi, Nasser M

    Published in International journal of general medicine (31-10-2022)
    “…Background: Alzheimer's disease is considered the most common neurodegenerative and progressive illness. It is also a common type of dementia characterized by…”
    Get full text
    Journal Article
  17. 17

    Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.gov by Alorfi, Nasser M, Alshehri, Fahad S

    Published in Journal of multidisciplinary healthcare (01-01-2023)
    “…Obesity in both adults and children is a primary health concern that can lead to many complications at a young age, including insulin resistance, type 2…”
    Get full text
    Journal Article
  18. 18

    Saudi Adults' Understanding and Views of Weight Management Practices and Obesity by Alshehri, Fahad S, Alorfi, Nasser M

    Published in Diabetes, metabolic syndrome and obesity (01-01-2023)
    “…The rising prevalence of overweight and obesity presents a significant global challenge. This study aimed to investigate the understanding and views of weight…”
    Get full text
    Journal Article
  19. 19

    The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry by Alorfi, Nasser M, Ashour, Ahmed M

    Published in Diabetes, metabolic syndrome and obesity (30-09-2023)
    “…Background: Non-alcoholic fatty liver disease (NAFLD) is a predominant health condition across the world due to its rising prevalence and association with…”
    Get full text
    Journal Article
  20. 20